ABT
Abbott LaboratoriesDNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Execution on device launches, margin recovery, and stronger diagnostics demand drive re-rating toward peer multiples and the bull target.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta 0.0.
What can break
Regulatory approval delays or adverse outcomes
Momentum
13
Value
57
Sentiment
75
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $141.25 · Bull $170.10 · Bear $108.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-24 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $133.84
Why
Momentum13 · Δ7d +1.2
Value57 · Δ7d -0.1
Sentiment75 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
13
34% active weight
Current posture
7d trendFlat
Δ7d
+1.2
Δ21d
+7.1
Value
57
32% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.1
Sentiment
75
33% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade D. Momentum 13.2 / Value 56.8 / Sentiment 74.7
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$152.9B
Beta
0.75
Shares Out
1.74B
P/E (TTM)
15.8
P/S (TTM)
5.02
P/FCF (TTM)
76.53
Rev YoY
+6.9%
EPS YoY
-0.2%
Gross Margin
+56.2%
Op Margin
+17.5%
Net Debt
$6.16B
Current Ratio
1.70
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology